Cellular Logistics Selected to Present at Midwest Growth Capital Symposium

Cellular Logistics Selected to Present at Midwest Growth Capital Symposium

MADISON, WI, May 10, 2022 – Cellular Logistics, a Madison-area company that is creating a new way to restore heart function and help patients with heart damage has been chosen to present at the Midwest Growth Capital Symposium (MGCS) being held on May 17-18, 2022.

2022 Presenting Companies | Midwest Growth Capital Symposium 2022 (midwestgcs.com)

Cellular Logistics is launching new financing round to advance its product, Tandem™, to the next stage of product development, and moving toward human clinical testing. Tandem™, a novel, and patented biomaterial holds the promise of revitalizing the damaged heart by enabling unique combined therapeutic approaches for the world’s leading cause of death, heart failure. The company’s vision is to help create a path to a new generation of therapies to reverse the debilitating symptoms of heart failure; dramatically reducing re-hospitalization and enabling patients to live longer, healthier lives.


This year, MGCS will feature 60-70 pre-selected Midwest companies seeking seed, series-A, and series-B funding that span the Life Sciences, Healthcare, Tech, Food & Agriculture, and Energy sectors. Additionally, the Big 10’s Tech Transfer Pitch Track will highlight 30-40 companies. The virtual event will provide easy access to companies’ executive summaries and pre-recorded pitches.  Attendees will have the chance to connect with early-stage companies, angel investors, venture capitalists, technology transfer professionals, and leading entrepreneurs from the Midwest and beyond.


Press Contact:  Alex Vodenlich, alex@cellogistics.com